X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Researchers Working On Building Regenerating Bone Tissue

Content Team by Content Team
11th March 2022
in News
Allergan Expands PLEDGE Clinical Research

According to an announcement made on February 15, 2022, McGill University researchers adopted the Canadian Light Source (CLS) at the University of Saskatchewan to create a unique approach for manufacturing synthetic bone tissue. The discovery comes after more than 30 years of research by the scientific community to provide an artificial alternative to bone transplants for the repair of sick or damaged bones.

Bone tissue engineering is a fast-expanding science that focuses on growing bone cells on scaffolds in the lab and then transplanting these structures into the body to repair bone injury. The scaffolds, like the bone they resemble, require an interconnection of small and large pores to enable cells and nutrients to disseminate and aid in the formation of new bone tissue.

The McGill research team discovered a way to change the inner structure of a substance called graphene oxide to make it more favourable for bone tissue regeneration. Graphene oxide is a super-thin, super-strong material that’s finding its way into optics, electronics, chemistry, biology, and energy storage. When stem cells are placed on graphene oxide, they tend to change into bone-generating osteoblasts due to the material’s unique characteristics.

Researchers from McGill’s departments of Mining and Materials Engineering, Electrical Engineering, and Dentistry make up the multidisciplinary research team. The researchers discovered that freezing graphene oxide at two different temperatures after adding an emulsion of oil and water gave two distinct diameters of pores throughout the material.

When stem cells from mouse bone marrow were “seeded” into the now-porous framework, the cells proliferated and dispersed inside the network of pores, indicating that the new method could potentially be utilised to rebuild bone tissue in people.

In a company press release, Marta Cerruti, a materials engineering professor at McGill University, said, they showed that the scaffolds are totally biocompatible, that the cells are happy once users put them in there, and that they’re able to penetrate all the scaffold and colonise the whole scaffold. The researchers employed the CLS’s BioMedical Imaging and Therapy–bend magnet beamline to see the various sized pores inside the scaffolding, as well as the cells’ development and dissemination.

To their knowledge, this is the first time anyone has utilised synchrotron light to see the geometry of graphene oxide scaffolds, said Yiwen Chen, lead researcher and Cerruti’s collaborator. Widespread clinical implementation of this new technique may still be many years away, but the discovery could enable other researchers to understand more about how stem cells change into bone cells.

In a press release, Cerruti added that this might lead to a greater understanding of the genetics of skeletons that wouldn’t have been understood otherwise.  In the short term, they might be able to use lab methods to better understand bone and maybe come up with new medicines.

Previous Post

Moderna To Establish mRNA Vaccine Production Plant In Kenya

Next Post

Clinical Decision Support System Lowers Cardiovascular Risk

Related Posts

DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Drug Development

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

21st March 2025
Clinical Trials

Oracle Wins the Asia Pacific Biopharma Excellence Awards

21st March 2025
Clinical Trials

Bio-Rad to Acquire Stilla Technologies by Q3 2025

28th February 2025
Next Post
Clinical Decision Support System Lowers Cardiovascular Risk

Clinical Decision Support System Lowers Cardiovascular Risk

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In